Trial Details
Not RecruitingBasic Information
| Clinical ID | c5107 |
|---|---|
| Identifier | EUCTR2013-001123-39-DK |
| Trial Title | An open label study on safety and pharmacokinetics of an intravenous administered single dose of Feramyl 200 mg in healthy blood donors compared to a single dose of Feramyl 1000 mg in IBD patients to evaluate dose dependency and kinetics after 1 hour inf |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Healthy blood donors and anemic patients with inflammatory bowel disease MedDRA version: 14.1.Level: LLT.Classification code 10002295.Term: Anemia iron deficiency.System Organ Class: 100000004851.;Therapeutic ar |
| Interventions | Product Name: FeramylPharmaceutical Form: Concentrate and solvent for solution for injectionINN or Proposed INN: Iron (III) hydroxide hydroxyethyl starch glucopheptonic acid complexCAS Number: CAS 15Current Sponsor code: 03-01-0056 |
Participant Information
| Sponsor | SerumWerk Bernburg AG |
|---|---|
| City | NULL |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |